Skip Navigation


Human Molecular Genetics Advance Access originally published online on March 16, 2006
Human Molecular Genetics 2006 15(8):1365-1374; doi:10.1093/hmg/ddl058
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
15/8/1365    most recent
ddl058v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Google Scholar
Right arrow Articles by Bell, J. T.
Right arrow Articles by Farrall, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bell, J. T.
Right arrow Articles by Farrall, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact: journals.permissions@oxfordjournals.org

Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension

Jordana Tzenova Bell1,2, Chris Wallace3, Richard Dobson3, Steven Wiltshire2, Charles Mein3, Janine Pembroke3, Morris Brown4, David Clayton4, Nilesh Samani5, Anna Dominiczak6, John Webster7, G. Mark Lathrop8, John Connell6, Patricia Munroe3, Mark Caulfield3 and Martin Farrall1,2,*

1Department of Cardiovascular Medicine and 2Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK, 3Barts and The London School of Medicine and Dentistry, London, EC1M 6BQ, UK, 4Clinical Pharmacology and the Cambridge Institute of Medical Research, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 2QQ, UK, 5Cardiology Group, Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, LE3 9QP, UK, 6Division of Cardiovascular and Medical Sciences, University of Glasgow, Western Infirmary, Glasgow, G11 6NT, UK, 7Medicine and Therapeutics, Aberdeen Royal Infirmary, Aberdeen, AB9 2ZB, UK, 8Centre National de Genotypage, Evry 91057, Paris, France

* To whom correspondence should be addressed. Tel: +44 1865 287601; Fax: +44 1865 287501; Email: mfarrall{at}well.ox.ac.uk

Received December 7, 2005; Revised February 8, 2006; Accepted March 9, 2006

It is well established that gene interactions influence common human diseases, but to date linkage studies have been constrained to searching for single genes across the genome. We applied a novel approach to uncover significant gene–gene interactions in a systematic two-dimensional (2D) genome-scan of essential hypertension. The study cohort comprised 2076 affected sib-pairs and 66 affected half-sib-pairs of the British Genetics of HyperTension study. Extensive simulations were used to establish significance thresholds in the context of 2D genome-scans. Our analyses found significant and suggestive evidence for loci on chromosomes 5, 9, 11, 15, 16 and 19, which influence hypertension when gene–gene interactions are taken into account (5q13.1 and 11q22.1, two-locus lod score=5.72; 5q13.1 and 19q12, two-locus lod score=5.35; 9q22.3 and 15q12, two-locus lod score=4.80; 16p12.3 and 16q23.1, two-locus lod score=4.50). For each significant and suggestive pairwise interaction, the two-locus genetic model that best fitted the data was determined. Regions that were not detected using single-locus linkage analysis were identified in the 2D scan as contributing significant epistatic effects. This approach has discovered novel loci for hypertension and offers a unique potential to use existing data to uncover novel regions involved in complex human diseases.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
L. S.-H. Wu, C.-H. Hsieh, D. Pei, Y.-J. Hung, S.-W. Kuo, and E. Lin
Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPAR{gamma} and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes
Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3360 - 3366.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. Org, S. Eyheramendy, P. Juhanson, C. Gieger, P. Lichtner, N. Klopp, G. Veldre, A. Doring, M. Viigimaa, S. Sober, et al.
Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations
Hum. Mol. Genet., June 15, 2009; 18(12): 2288 - 2296.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C.-H. Hsieh, K.-H. Liang, Y.-J. Hung, L.-C. Huang, D. Pei, Y.-T. Liao, S.-W. Kuo, M. S.-J. Bey, J.-L. Chen, and E. Y. Chen
Analysis of epistasis for diabetic nephropathy among type 2 diabetic patients
Hum. Mol. Genet., September 15, 2006; 15(18): 2701 - 2708.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.